R.H.B. Meyboom
- Toxicology top 0.5%
- Pharmacology top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 10%
- Co-authors
- Marie L. De BruinMonica PetterssonRené RoyerArno W. HoesHubert G.M. LeufkensToine C. G. EgbertsFred H.P. De KoningH.G.M. Leufkens
- Topics
- Pharmacovigilance and Adverse Drug Reactions (8 papers)Pharmacological Effects and Toxicity Studies (6 papers)Drug-Induced Adverse Reactions (5 papers)
- Partner nations
- NetherlandsSwedenCzechia
In The Last Decade
R.H.B. Meyboom
44 papers receiving 744 citations
Peers
Comparison fields: 5 of 121
- Toxicology 236
- Pharmacology 166
- Cardiology and Cardiovascular Medicine 152
- Molecular Biology 137
- Pediatrics, Perinatology and Child Health 124
Countries citing papers authored by R.H.B. Meyboom
This map shows the geographic impact of R.H.B. Meyboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.H.B. Meyboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.H.B. Meyboom more than expected).
Fields of papers citing papers by R.H.B. Meyboom
This network shows the impact of papers produced by R.H.B. Meyboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.H.B. Meyboom. The network helps show where R.H.B. Meyboom may publish in the future.
Co-authorship network of co-authors of R.H.B. Meyboom
This figure shows the co-authorship network connecting the top 25 collaborators of R.H.B. Meyboom. A scholar is included among the top collaborators of R.H.B. Meyboom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.H.B. Meyboom. R.H.B. Meyboom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 63 | |
| 6 | 15 | |
| 7 | 12 | |
| 8 | 13 | |
| 9 | 90 | |
| 10 | 4 | |
| 11 | [Liver damage caused by ranitidine]. | 2 |
| 12 | 19 | |
| 13 | 21 | |
| 14 | 11 | |
| 15 | 3 | |
| 16 | 35 | |
| 17 | 8 | |
| 18 | 5 | |
| 19 | [Hepatitis caused by glaphenine]. | 0 |
| 20 | 3 |
About R.H.B. Meyboom
R.H.B. Meyboom is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 45 papers that have together received 800 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Drug-Induced Adverse Reactions (5 papers). The work is most often cited by research in Toxicology (236 citations), Geriatrics and Gerontology (45 citations) and Pharmacology (166 citations). R.H.B. Meyboom has collaborated with scholars based in Netherlands, Sweden and Czechia. Frequent co-authors include Marie L. De Bruin, Monica Pettersson, René Royer, Arno W. Hoes, Hubert G.M. Leufkens, Toine C. G. Egberts, Fred H.P. De Koning, H.G.M. Leufkens, Maartje Smulders and Gerrit ten Brinke. Their work appears in journals such as The Lancet, Macromolecules and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.